Maynard Um
-
-
-
-
-
-
-
Delcath Systems reports study showing liver therapy benefits for melanoma
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Delcath Systems (DCTH)
-
-
-
-
-
-
-
Delcath Systems (DCTH) PT Raised to $24 at H.C. Wainwright
-
-
-
-
-
-
-
Delcath Systems (DCTH) Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Colorectal Cancer
-
-
-
-
-
-
-
Delcath Systems (DCTH) Misses Q2 EPS by 12c
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

